Rondol

rondol

Rondol partners with Arkema and Concordia University for battery innovation

Rondol Industrie has signed a five-year collaborative agreement with world-leading material sciences company Arkema and Concordia University in Canada. The partnership between the three entities promises to stimulate progress in the battery industry, as the use of renewable energy in society continues to increase. The partners are combining efforts to explore the benefits of an …

Rondol partners with Arkema and Concordia University for battery innovation Read More »

A Comparative Overview of Hot Melt Extrusion and Spray Drying in Pharmaceutical Manufacturing

Hot Melt Extrusion and Spray Drying are two distinct technologies employed in the pharmaceutical industry to enhance drug formulations. Let’s take a closer look at these methods and compare their key features. In terms of common strong points, both Hot Melt Extrusion and Spray Drying share the goal of improving the release profile of all …

A Comparative Overview of Hot Melt Extrusion and Spray Drying in Pharmaceutical Manufacturing Read More »

Extrusion for pharma applications: An update

Victoire de Margerie (CEO of Rondol), Pascal Boulet (Institut Jean Lamour), and MaĂ«l Gallas (Rondol) published a new article in SPE Polymers about our current research and development on hot-melt extrusion (HME) for drug delivery and pharmaceutical formulation. Unfortunately, a large percentage of marketed drugs (40%) and those in the development pipeline (90%) are poorly water …

Extrusion for pharma applications: An update Read More »

Child Friendly Anti Malarials

On World Malaria Day dedicated to Innovation, RONDOL together with BASF and Queens University Belfast can display improved dissolution results of a newly formulated Fixed Dose Combination (FDC) of Artemether and Lumefantrine thanks to using hot melt #extrusion technology as a continuous manufacturing platform. FDC of Artemether (AT) and Lumefantrine (LM) are the 1st line …

Child Friendly Anti Malarials Read More »

White Paper on Aspirin

1st result of the Technology cooperation between RONDOL and SEQENS announced in March. AcetylSalicylic Acid (ASA better known as Aspirin) is one of the most popular Non-Steroidal Anti-Inflammatory Drugs (NSAID) in the world. First used as pain killer, Aspirin also brings lesser-known benefits that can be essential to prevent cardiovascular events. Further applications are currently …

White Paper on Aspirin Read More »

Aspirin for oncology therapies

New milestone on the RONDOL SEQENS joint cooperation to improve bioavailability of selected molecules with the successful installation of our first GMP vertical extrusion line at the SEQENS LAB in Porcheville.

Rondol and Seqens Award by l’Usine Nouvelle

Happy to receive the Trophée Initiative Chimie that highlights the potential to improve bioavailability of active principles and reduce the capital intensity of their manufacturing thanks to extrusion. Follow the link below to read the entire article. https://www.usinenouvelle.com/article/relation-fournisseur-client-palmares-haut-de-gamme-pour-la-2e-edition-des-trophees-initiatives-chimie.N1778262